CK Life Sciences Int'l., (Holdings) Inc. (0775.HK)
HKD 0.93
(3.33%)
HKD 0.93
(3.33%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 739.25 Million HKD | -47.64% |
| 2022 | 1.38 Billion HKD | 101.78% |
| 2021 | 685.85 Million HKD | 5.88% |
| 2020 | 647.79 Million HKD | -0.35% |
| 2019 | 650.04 Million HKD | 11.19% |
| 2018 | 584.6 Million HKD | -0.35% |
| 2017 | 586.66 Million HKD | -0.9% |
| 2016 | 592.01 Million HKD | 6.97% |
| 2015 | 553.42 Million HKD | -2.06% |
| 2014 | 565.03 Million HKD | 0.86% |
| 2013 | 560.2 Million HKD | 10.27% |
| 2012 | 508.04 Million HKD | 16.86% |
| 2011 | 434.75 Million HKD | 208.83% |
| 2010 | 140.77 Million HKD | 16.59% |
| 2009 | 120.74 Million HKD | -89.45% |
| 2008 | 1.14 Billion HKD | 71.35% |
| 2007 | 668.13 Million HKD | -2.29% |
| 2006 | 683.8 Million HKD | 1935.49% |
| 2005 | 33.59 Million HKD | -82.67% |
| 2004 | 193.86 Million HKD | 2003.32% |
| 2003 | 9.21 Million HKD | -85.11% |
| 2002 | 61.89 Million HKD | 6.82% |
| 2001 | 57.94 Million HKD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 391 Million HKD | 0.0% |
| 2023 Q2 | 332.31 Million HKD | 0.0% |
| 2023 Q4 | 391.54 Million HKD | 0.0% |
| 2023 FY | 724.54 Million HKD | -47.64% |
| 2022 Q4 | 425.21 Million HKD | 0.0% |
| 2022 Q2 | 322.71 Million HKD | 0.0% |
| 2022 FY | 1.38 Billion HKD | 101.78% |
| 2021 Q2 | 297.5 Million HKD | 0.0% |
| 2021 FY | 685.85 Million HKD | 5.88% |
| 2021 Q4 | 409.99 Million HKD | 0.0% |
| 2020 Q2 | 240.36 Million HKD | 0.0% |
| 2020 FY | 647.79 Million HKD | -0.35% |
| 2020 Q4 | 433.99 Million HKD | 0.0% |
| 2019 FY | 650.04 Million HKD | 11.19% |
| 2019 Q4 | 681.75 Million HKD | 0.0% |
| 2019 Q2 | 545.62 Million HKD | 0.0% |
| 2018 Q4 | 611.71 Million HKD | 0.0% |
| 2018 FY | 584.6 Million HKD | -0.35% |
| 2018 Q2 | 583.53 Million HKD | 0.0% |
| 2017 FY | 586.66 Million HKD | -0.9% |
| 2017 Q2 | 544.28 Million HKD | 0.0% |
| 2017 Q4 | 582.62 Million HKD | 0.0% |
| 2016 FY | 592.01 Million HKD | 6.97% |
| 2016 Q4 | 593.66 Million HKD | 0.0% |
| 2016 Q2 | 613.38 Million HKD | 0.0% |
| 2015 FY | 553.42 Million HKD | -2.06% |
| 2015 Q2 | 605.24 Million HKD | 0.0% |
| 2015 Q4 | 785.58 Million HKD | 0.0% |
| 2014 FY | 565.03 Million HKD | 0.86% |
| 2014 Q2 | 607.11 Million HKD | 0.0% |
| 2014 Q4 | 710.16 Million HKD | 0.0% |
| 2013 Q2 | 640.59 Million HKD | 0.0% |
| 2013 FY | 560.2 Million HKD | 10.27% |
| 2013 Q4 | 703.12 Million HKD | 0.0% |
| 2012 FY | 508.04 Million HKD | 16.86% |
| 2012 Q4 | - HKD | 0.0% |
| 2012 Q2 | - HKD | 0.0% |
| 2011 Q2 | - HKD | 0.0% |
| 2011 FY | 434.75 Million HKD | 208.83% |
| 2011 Q4 | - HKD | 0.0% |
| 2010 Q4 | - HKD | 0.0% |
| 2010 FY | 140.77 Million HKD | 16.59% |
| 2010 Q2 | - HKD | 0.0% |
| 2009 FY | 120.74 Million HKD | -89.45% |
| 2009 Q4 | - HKD | 0.0% |
| 2008 FY | 1.14 Billion HKD | 71.35% |
| 2007 FY | 668.13 Million HKD | -2.29% |
| 2006 FY | 683.8 Million HKD | 1935.49% |
| 2005 FY | 33.59 Million HKD | -82.67% |
| 2004 FY | 193.86 Million HKD | 2003.32% |
| 2003 FY | 9.21 Million HKD | -85.11% |
| 2002 FY | 61.89 Million HKD | 6.82% |
| 2001 FY | 57.94 Million HKD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 325.05 Million HKD | -127.428% |